Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Wild-type (wt)
p53
can act as a sequence-specific transcriptional activator and it is believed that
p53
elicits at least part of its biological effects by regulating the expression of specific target genes. By using a differential subtractive hybridization approach in a murine cell line stably transfected with a temperature-sensitive
p53
mutant (Val135), we isolated a set of genes markedly induced by wt
p53
. One of them, provisionally named
B99
, was further characterized; its transcriptional induction was dependent on wt
p53
function and the corresponding protein product was shown to accumulate after DNA damage in different cell types. Immunofluorescence analysis located the
B99 protein
to the microtubule network. Flow cytometry revealed that upon activation of
p53
function the endogenous
B99 protein
was selectively induced in the G2 fraction of the cell population. When
B99
was ectopically expressed in
p53
-null murine fibroblasts,
B99
-transfected cells displayed an increased fraction with a 4N DNA content, indicative of interference with G2 phase progression. Taken together these data suggest that
B99
might play a role in mediating specific biological activities of wt
p53
during the G2 phase.
...
PMID:A novel p53-inducible gene coding for a microtubule-localized protein with G2-phase-specific expression. 972 37
Murine Gtse-1 (G(2) and S phase expressed protein), previously named
B99
, is a wt-
p53
inducible gene that encodes a microtubule-localized protein which is able to induce G(2)/M phase accumulation when ectopically expressed. Here we report the cloning and characterization of a new cDNA (
GTSE-1
) encoding a human homologue of the mouse Gtse-1 protein. Chromosome mapping of mouse and human genes assigned Gtse-1 to chromosome 15 and
GTSE-1
to chromosome 22q13.2-q13.3 in a region with conserved synteny to that where Gtse-1 mapped. Analysis of the genomic structure revealed that
GTSE-1
contains at least 11 exons and 10 introns, spanning approximately 33kb of genomic DNA. Similar to murine Gtse-1, the product of
GTSE-1
localized to the microtubules, was able to delay G(2)/M progression when ectopically expressed and was cell cycle regulated. Taken together, these results indicate
GTSE-1
as the human functional homologue of murine Gtse-1.
...
PMID:Cloning, chromosome mapping and functional characterization of a human homologue of murine gtse-1 (B99) gene. 1097 54
B99
is a
p53
-inducible gene whose accumulation upon
p53
activation is restricted to late S/G2 cells. Here we have analyzed
B99
regulation during the cell cycle in murine cells with or without functional
p53
. We report that
B99
accumulates in late S/G2 phase, is phosphorylated in mitosis, and disappears in G1 phase, regardless of the status of
p53
. As a complement to this observation, we show that
B99
is not induced by
p53
in quiescent cells. Therefore,
B99
expression is modulated both by cell-cycle regulatory mechanisms and by
p53
, and
p53
can increase the cellular levels of
B99
only during the window of the cell cycle when it is normally expressed. On the basis of these observations we rename
B99
Gtse-1 (G-two- and S-phase-expressed).
...
PMID:Cell-cycle regulation of the p53-inducible gene B99. 1098 15
p53
protects mammals from neoplasia by inducing apoptosis, DNA repair and cell cycle arrest in response to a variety of stresses.
p53
-dependent arrest of cells in the G1 phase of the cell cycle is an important component of the cellular response to stress. Here we review recent evidence that implicates
p53
in controlling entry into mitosis when cells enter G2 with damaged DNA or when they are arrested in S phase due to depletion of the substrates required for DNA synthesis. Part of the mechanism by which
p53
blocks cells at the G2 checkpoint involves inhibition of Cdc2, the cyclin-dependent kinase required to enter mitosis. Cdc2 is inhibited simultaneously by three transcriptional targets of
p53
, Gadd45, p21, and 14-3-3 sigma. Binding of Cdc2 to Cyclin B1 is required for its activity, and repression of the cyclin B1 gene by
p53
also contributes to blocking entry into mitosis.
p53
also represses the cdc2 gene, to help ensure that cells do not escape the initial block. Genotoxic stress also activates
p53
-independent pathways that inhibit Cdc2 activity, activation of the protein kinases Chk1 and Chk2 by the protein kinases Atm and Atr. Chk1 and Chk2 inhibit Cdc2 by inactivating Cdc25, the phosphatase that normally activates Cdc2. Chk1, Chk2, Atm and Atr also contribute to the activation of
p53
in response to genotoxic stress and therefore play multiple roles.
p53
induces transcription of the reprimo,
B99
, and mcg10 genes, all of which contribute to the arrest of cells in G2, but the mechanisms of cell cycle arrest by these genes is not known. Repression of the topoisomerase II gene by
p53
helps to block entry into mitosis and strengthens the G2 arrest. In summary, multiple overlapping
p53
-dependent and
p53
-independent pathways regulate the G2/M transition in response to genotoxic stress.
...
PMID:Regulation of the G2/M transition by p53. 1131 28
GTSE-1
(G2 and S phase-expressed-1) protein is specifically expressed during S and G2 phases of the cell cycle. It is mainly localized to the microtubules and when overexpressed delays the G2 to M transition. Here we report that human
GTSE-1
(hGTSE-1) protein can negatively regulate
p53
transactivation function, protein levels, and
p53
-dependent apoptosis. We identified a physical interaction between the C-terminal regulatory domain of
p53
and the C-terminal region of hGTSE-1 that is necessary and sufficient to down-regulate
p53
activity. Furthermore, we provide evidence that hGTSE-1 is able to control
p53
function in a cell cycle-dependent fashion. hGTSE-1 knock-down by small interfering RNA resulted in a S/G2-specific increase of
p53
levels as well as cell sensitization to DNA damage-induced apoptosis during these phases of the cell cycle. Altogether, this work suggests a physiological role of hGTSE-1 in apoptosis control after DNA damage during S and G2 phases through regulation of
p53
function.
...
PMID:The cell cycle-regulated protein human GTSE-1 controls DNA damage-induced apoptosis by affecting p53 function. 1275 Mar 68
In response to various forms of cellular stress, including DNA damage, ribonucleotide depletion, and abnormal proliferative signals,
p53
becomes activated as a transcription factor, targeted genes that induce cell-cycle arrest and apoptosis. Eliminating damaged, stressed, or abnormally proliferating cells from the replicating cell population prevents the propagation of potentially cancer-prone cells. Here we focus on the transcriptional targets of
p53
that regulate the cell cycle.
p53
Induction of G1/ S cell-cycle arrest is largely attributed to the transcriptional upregulation of p21WAF1, and more recently, to the transcriptional repression of c-MYC. The role of
p53
in G2/M cell-cycle arrest in response to DNA damage is more complex, involving multiple targets that can generally be considered to impinge upon either the cell cycle (e.g., Cyclin-B, cdc2, cdc25C) or the mitotic machinery (i.e., Topoisomerase II,
B99
/Gtse-1, and MAP4). The ability of
p53
to regulate these two type of gene targets may reflect
p53
-mediated early versus late events in the G2/M cell-cycle arrest response. Together the information presented illustrates the need for further studies to precisely delineate the nature of G2/M cell-cycle arrest in response to cell stress, and defines the role of
p53
in what is likely an important mechanism of tumor suppression.
...
PMID:Transcriptional targets of p53 that regulate cellular proliferation. 1736 86